The Lumbar Disc Herniation Treatment Market in 2023 is US$ 2.83 million, and is expected to reach US$ 4.65 million by 2031 at a CAGR of 6.42%.
FutureWise Research published a report that analyzes Lumbar Disc Herniation Treatment Market trends to predict the market's growth. The report begins with a description of the business environment and explains the commercial summary of the chain structure. Based on the market trends and driving factors presented in the report, clients will be able to plan the roadmap for their products and services taking into account various socio-economic factors.
Additionally, it illustrates the corporate profiles and situation of competitive landscape amongst numerous associated corporations including the analysis of market evaluation and options associated with the worth chain. This Lumbar Disc Herniation Treatment research report provides insights on market overview, market segmentation, current and future pricing, growth analysis, competitive landscape and other such premium insights within the forecast period.
Request a Sample Report @ Request for Lumbar Disc Herniation Treatment Market Sample
Lumbar Disc Herniation Treatment Market Segmentation:
By Location Type
· Axillary
· Foraminal
· Posterolateral
· Central Prolapse
By Diagnosis
· Nerve Tests
· Electromyography (EMG)
· Nerve conduction study
· Imaging Tests
· Magnetic resonance imaging (MRI)
· Myelogram
· Computerized tomography (CT) scan
· X-rays
· Others
By Treatment
· Medication
· Non-steroidal anti-inflammatory drugs (NSAIDs)
· Opioids
· Muscle relaxers
· Local corticosteroid injections (CSI)
· Surgery
· Far lateral microdiskectomy
· Laminotomy and discectomy
· Physical Therapy
· Others
By Type
· Chronic
· Acute
By Dosage Form
· Injection
· Tablets
· Others
By Route of Administration
· Parenteral
· Oral
· Others
By End-Users
· Hospitals
· Specialty Clinics
· Homecare
· Others
By Distribution Channel
· Hospital Pharmacy
· Retail Pharmacy
· Online Pharmacy
· Others
By Region
· North America
· Europe
· Asia-Pacific
· Latin America
· Middle East and Africa
Major players included in the Lumbar Disc Herniation Treatment Market:
· Pfizer, Inc.
· GlaxoSmithKline plc
· Novartis AG
· Teva Pharmaceutical Industries Ltd.
· Sanofi
· Boehringer Ingelheim International GmbH.
· AstraZeneca
· Johnson and Johnson Private Limited
· MerckCo., Inc.
· F. Hoffmann-La Roche Ltd.
· Sun Pharmaceutical Industries Ltd.
· Aurobindo Pharma
·
